Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10900	Companies
237540	Keywords
166452	Articles
127572	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 08/28/2026 at 14:49, 3 days ago

Jaguar Health's Financial Position Reviewed Amid Strategic Shifts

Jaguar Health Financial Restructuring Strategic Transition Q2 2026 Results Liquidity Buffer
PRESS RELEASE

published on 08/28/2026 at 14:44, 3 days ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review
First Berlin Equity Research published an update on Jaguar Health Inc, maintaining an 'UNDER REVIEW' rating and price target. Q2/26 results in line with expectations, strategic transformations noted, and balance sheet strengthened

Jaguar Health Inc First Berlin Equity Research Balance Sheet Strategic Transformations Q2/26 Results
BRIEF

published on 08/26/2026 at 15:05, 5 days ago

Jaguar Health Launches Neonorm Dog for Digestive Support

Companion Animals Jaguar Health Digestive Health Neonorm Dog Plant-based Product
PRESS RELEASE

published on 08/26/2026 at 15:00, 5 days ago

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Jaguar Health, Inc. announced the commercial launch of Neonorm Dog, a plant-based product for normal stool consistency and GI fluid balance in dogs, set to be available on Amazon and Chewy

Jaguar Health Dog Owners Neonorm Dog Plant-based Product Amazon Chewy
BRIEF

published on 08/19/2026 at 22:05, 11 days 17 hours ago

Jaguar Health Q2 2026 Financial Results Overview

Jaguar Health Crofelemer Development Net Loss Increase Future Pak Agreement Q2 2026 Financials
PRESS RELEASE

published on 08/19/2026 at 22:00, 11 days 17 hours ago

Jaguar Health Reports Second Quarter 2026 Financials
Jaguar Health, Inc. updates on crofelemer development for pediatric intestinal failure diseases at ESPGHAN 2026; financial results and licensee agreements announced for Q2 2026

Financial Results Crofelemer Jaguar Health Pediatric IF Licensee Agreements
BRIEF

published on 08/18/2026 at 15:05, 13 days ago

Jaguar Health Announces Investor Webcast for Q2 2026 Financial Review

Investor Webcast Jaguar Health Corporate Updates Q2 2026 Financials Gastrointestinal Drugs
PRESS RELEASE

published on 08/18/2026 at 15:00, 13 days ago

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
Jaguar Health, Inc. to file Earnings Report on August 19, 2026 for quarter ending June 30, 2026. Investor webcast scheduled to review financials and provide updates

Earnings Report Investor Webcast Jaguar Health Financials Corporate Updates
BRIEF

published on 08/05/2026 at 15:05, 26 days ago

Jaguar Health Meets Conditions for $2 Million Payment from Future Pak

Jaguar Health Pediatric Intestinal Failure Future Pak Non-dilutive Payment Crofelemer Drug
PRESS RELEASE

published on 08/05/2026 at 15:00, 26 days ago

Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
Jaguar Health receives $16M upfront payment in U.S. license agreement with Future Pak for crofelemer drugs. Presentation at ESPGHAN 2026 reveals positive results of crofelemer therapy for pediatric IF

Jaguar Health Crofelemer Drugs US License Agreement Pediatric IF ESPGHAN 2026

Accesswire

Published on 08/31/2026 at 15:00, 5 minutes ago

Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 14:30, 35 minutes ago

Boron One Holdings Inc. Project Update
Published on 08/31/2026 at 14:30, 35 minutes ago

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles
Published on 08/31/2026 at 13:30, 1 hour 35 minutes ago

Nextech3D.ai Delivers 101% Revenue Growth in Fiscal Q1 2027 as AI-Powered Event Platform Accelerates
Published on 08/31/2026 at 13:30, 1 hour 35 minutes ago

Condor Receives Environmental Permit (DIA) for Drilling at Flagship Pucamayo Project

View all ACCESSWIRE

EQS Group

Published on 08/31/2026 at 14:59, 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/31/2026 at 14:35, 30 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.90 Million Tokens, and Total Crypto and Total Cash Holdings of $15.6 Billion
Published on 08/31/2026 at 13:55, 1 hour 10 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 08/31/2026 at 13:31, 1 hour 33 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 08/31/2026 at 12:47, 2 hours 18 minutes ago

hep global successfully develops two solar projects with battery storage systems west of Munich

Les Echos

Published on 08/31/2026 at 12:00, 3 hours 5 minutes ago

Capital increase through exercise of subscription rights
Published on 08/31/2026 at 07:00, 8 hours 5 minutes ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Published on 08/28/2026 at 06:55, 3 days 8 hours ago

Recticel Accelerates Profitable Growth
Published on 08/26/2026 at 18:02, 4 days 21 hours ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 4 days 21 hours ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

View all LES ECHOS COMFI WIRE